The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Effects of long‐term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five‐year, randomized, placebo‐controlled trial
Open accessAbstract
Objective: This study was undertaken to assess the effect of strontium ranelate on nonvertebral and vertebral fractures in postmenopausal women with osteoporosis in a 5‐year, double‐blind, placebo‐controlled trial. Methods: A total of 5,091 postmenopausal women with osteoporosis were randomized to receive either strontium ranelate at 2 gm/day or placebo for 5 years. The main efficacy criterion was the incidence of nonvertebral fractures. In addition, incidence of hip fractures was assessed, by post hoc analysis, in the subset of 1,128 patients who were at high risk of fractures (age 74 years or older with lumbar spine and femoral neck bone mineral density T scores −2.4 or less). The incidence of new vertebral fractures was assessed, using the semiquantitative method described by Genant, in the 3,646 patients in whom spinal radiography (a nonmandatory procedure) was performed during the course of the study. Fracture data were analyzed using the Kaplan‐Meier survival method. Results: Of the 5,091 patients, 2,714 (53%) completed the study up to 5 years. The risk of nonvertebral fracture was reduced by 15% in the strontium ranelate group compared with the placebo group (relative risk 0.85 [95% confidence interval 0.73–0.99]). The risk of hip fracture was decreased by 43% (relative risk 0.57 [95% confidence interval 0.33–0.97]), and the risk of vertebral fracture was decreased by 24% (relative risk 0.76 [95% CI 0.65–0.88]) in the strontium ranelate group. After 5 years, the safety profile of strontium ranelate remained unchanged compared with the 3‐year findings. Conclusion: Our findings indicate that treatment of postmenopausal osteoporosis with strontium ranelate results in a sustained reduction in the incidence of osteoporotic nonvertebral fractures, including hip fractures, and vertebral fractures over 5 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and outcomes of osteoporotic fractures
Cummings, S. R., & Melton, L. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08657-9 · Cited by 3,821
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
World-wide Projections for Hip Fracture
Gullberg, B., Johnell, O., & Kanis, J. A. (1997) · Osteoporosis International · doi:10.1007/pl00004148 · Cited by 2,285
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Self-citationMeunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E.-M., Pors-Nielsen, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa022436 · Cited by 1,638
Self-citationReginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580
Self-citationBlack, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Reginster, J. Y., Seeman, E., De Vernejoul, M. C., Adami, S., Compston, J., Phenekos, C., Devogelaer, J. P., Curiel, M. D., Sawicki, A., Goemaere, S., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1774 · Cited by 1,071
Self-citationEffects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Mortality after osteoporotic fractures
Johnell, O., Kanis, J. A., Odén, A., Sernbo, I., Redlund-Johnell, I., Petterson, C., De Laet, C., & Jönsson, B. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1490-4 · Cited by 848
Mechanisms of Action and Therapeutic Potential of Strontium in Bone
Marie, P. J., Ammann, P., Boivin, G., & Rey, C. (2001) · Calcified Tissue International · doi:10.1007/s002230010055 · Cited by 689
Delmas, P. D., Ensrud, K. E., Adachi, J. D., Harper, K. D., Sarkar, S., Gennari, C., Reginster, J., Pols, H. A. P., Recker, R. R., Harris, S. T., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3609 · Cited by 563
Self-citationFractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation
Melton, L. J., Thamer, M., Ray, N. F., Chan, J. K., Chesnut, C. H., Einhorn, T. A., Johnston, C. C., Raisz, L. G., Silverman, S. L., & Siris, E. S. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.16 · Cited by 535
Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis
Mellström, D. D., Sörensen, O. H., Goemaere, S., Roux, C., Johnson, T. D., & Chines, A. A. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0286-7 · Cited by 350
Self-citationSkeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1
Tonino, R. P., Meunier, P. J., Emkey, R., Rodriguez-Portales, J. A., Menkes, C.-J., Wasnich, R. D., Bone, H. G., Santora, A. C., Wu, M., Desai, R., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6777 · Cited by 335
Self-citationEnsrud, K. E., Barrett-Connor, E. L., Schwartz, A., Santora, A. C., Bauer, D. C., Suryawanshi, S., Feldstein, A., Haskell, W. L., Hochberg, M. C., Torner, J. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040326 · Cited by 275
Sorensen, O. H., Crawford, G. M., Mulder, H., Hosking, D. J., Gennari, C., Mellstrom, D., Pack, S., Wenderoth, D., Cooper, C., & Reginster, J.-Y. (2003) · Bone · doi:10.1016/s8756-3282(02)00946-8 · Cited by 254
Self-citationIn vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation
Baron, R., & Tsouderos, Y. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02040-x · Cited by 251
Siris, E. S., Harris, S. T., Eastell, R., Zanchetta, J. R., Goemaere, S., Diez-Perez, A., Stock, J. L., Song, J., Qu, Y., Kulkarni, P. M., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050509 · Cited by 243
Self-citationSkeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women
Tonino, R. P. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3109 · Cited by 188
Nielsen, S. P., Slosman, D. O., Sørensen, O. H., Basse‐Cathalinat, B., de Cassin, P., Roux, C., & Meunier, P. J. (1999) · Journal of Clinical Densitometry · doi:10.1016/s1094-6950(06)60402-2 · Cited by 114
Self-citationA model of osteoporosis impact in Switzerland 2000–2020
Schwenkglenks, M. M., Lippuner, K., Häuselmann, H. J., & Szucs, T. D. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1743-x · Cited by 56
Meunier, P. J., & Reginster, J.-Y. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1341-8 · Cited by 47
Self-citationHealth care costs of women with symptomatic vertebral fractures
Puffer, S., Torgerson, D. J., Sykes, D., Brown, P., & Cooper, C. C. (2004) · Bone · doi:10.1016/j.bone.2004.03.035 · Cited by 35
Cited by
UK clinical guideline for the prevention and treatment of osteoporosis
The National Osteoporosis Guideline Group (NOGG), Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 826
The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro
Gentleman, E., Fredholm, Y. C., Jell, G., Lotfibakhshaiesh, N., O'Donnell, M. D., Hill, R. G., & Stevens, M. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.121 · Cited by 635
Li, Y., Li, Q., Zhu, S., Luo, E., Li, J., Feng, G., Liao, Y., & Hu, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.112 · Cited by 282
Vitamin K to prevent fractures in older women: systematic review and economic evaluation
Stevenson, M., Lloyd-Jones, M., & Papaioannou, D. (2009) · Health Technology Assessment · doi:10.3310/hta13450 · Cited by 90
Metadata
- Authors
- Reginster, J., Felsenberg, D., Boonen, S., Diez‐Perez, A., Rizzoli, R., Brandi, M., Spector, T. D., Brixen, K., Goemaere, S., Cormier, C., Balogh, A., Delmas, P. D., & Meunier, P. J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2008-05-31
- Volume
- 58
- Issue
- 6
- Pages
- 1687-1695
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2042450573
- Cited by
- 261
- References
- 28
- FWCI
- 34.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.